Guangzhou to build biomedicine hundreds of billions of industrial groups

In the summer, walk into the Guanqi Life and Health Science and Technology Park located in the guangzhou Development Zone in , in the experimental production building, each small laboratory, is loaded with a start-up in the biomedical industry development dream. "In addition to technology, we have to start a lot of things in the mainland from scratch, but also as a start-up." Here, the park can help us to solve the company's registration, research and development sites and product approval and other matters, so that we can focus more on product development, so that products more quickly on the mainland market "Mr Lu, an entrepreneur from Hong Kong, is frank and has chosen Guangzhou as the starting point for innovation and entrepreneurship in the Mainland, focusing on the environment and advantages of research and development and industrial transformation in the field of biomedicine . driven by innovation, Guangzhou biopharmaceutical industry cluster has been growing in recent years At present, the formation of biomedicine, large health products and health services and other advantages of the industry And to the Broad Pharmaceutical Group as the representative of the leading pharmaceutical enterprise cluster, but also gathered more than 400 research and development production enterprises. reporters learned yesterday from the Municipal Industry and Information Technology Commission, the recent introduction of the "Guangzhou City Industrial Transformation and Upgrade Battle three-year action implementation plan (2015-2017)," Guangzhou will further increase innovation drive efforts, and strive to 2017, the city's biopharmaceutical industry to build a for 100 billion -scale industrial clusters. , the relevant person in charge of Guangzhou Development Zone, as a leading enterprise in the field of regenerative medical materials in China, Crown Bio from the International Business Incubator incubation of Science City after graduation, the establishment of the Crown Bio-Industrial Park and Crown Life and Health Science and Technology Park, the construction of a GMP-certified experimental production building, for the entry of science and technology projects to provide funds, experimental sites, sales channels and other full range of incubation services, to achieve small micro-enterprises "pack into", to promote the industrialization of scientific research results They introduced more mature scientific research achievements in universities and scientific research institutions, encouraged the innovation of internal research and development teams internally, and maintained a virtuous circle of incubation projects At present, more than 5000 square meters of the first phase of incubation site has been saturated, the number of enterprises into 23, is expected to 2016, the output value of the Guanguan Science and Technology Park alone can reach 2 billion yuan. in recent years, the Guangzhou Development Zone bio-pharmaceutical industry cluster continues to grow, is directly related to such incubators Based on this, the current Guangzhou biopharmaceutical industry cluster has formed a "two-center multi-regional" layout, that is, Guangzhou Science City as the core of the industrial incubation center, Guangzhou International Bio-Island as the core of the industrial innovation center, Baiyun Biopharmaceutical Park, Panyu Biopharmaceutical Base and from the chemical biopharmaceutical base and other regions (county-level cities) characteristic industrial park for the radiation area of the industrial layout, with a more complete technology research and development and pilot, product manufacturing and technology services industry chain. reporter learned from the SASAC of Guangzhou City, as a wholly state-owned enterprise in Guangzhou, Guangzhou Pharmaceutical Group last year achieved sales revenue of nearly 65 billion yuan, not only guangzhou's second largest enterprise group, but also the country's largest pharmaceutical enterprise group Not long ago, the State Food and Drug Administration Of the Southern Institute of Pharmaceutical Economics announced the top 100 list of China's pharmaceutical industry, Guang Pharmaceutical Group for four consecutive years topped the list, "China's largest pharmaceutical enterprises" crown At the same time, as a leading enterprise, its investment in innovation, in the past year has attracted the attention of the industry On March 27, 2014, Guang Pharma Group announced the introduction of the "Original 1.1 Target Ingindividual Anti-Tumor Drug Development and Industrialization Innovation Team" and was selected as the fourth batch of innovation team in Guangdong Province. Guangzhou has a complete pharmaceutical industry, industry and research technology innovation system, formed by more than 10 institutions of higher learning, more than 40 research institutes, more than 70 provincial-level key disciplines, 5 national key laboratories, 7 national engineering and technology research centers (engineering laboratories) and more than 400 research and development-oriented enterprises composed of biopharmaceutical technology innovation network, engineering research and industrialization capabilities are increasingly prominent, become one of China's important sources of pharmaceutical innovation.